Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal women

Background: Hominis placenta pharmacopuncture is widely used for climacteric symptoms. This study examined the efficacy and safety of pharmacopuncture with PLC (the extract of Hominis placenta) on hot flashes for perimenopausal and postmenopausal women. Methods: This study was a randomized placebo-c...

Full description

Saved in:
Bibliographic Details
Main Authors: Su-Ji Choi, Dong-Il Kim, Sang Ho Yoon, Chang-Min Choi, Jeong-Eun Yoo
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Integrative Medicine Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213422022000580
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850249832870969344
author Su-Ji Choi
Dong-Il Kim
Sang Ho Yoon
Chang-Min Choi
Jeong-Eun Yoo
author_facet Su-Ji Choi
Dong-Il Kim
Sang Ho Yoon
Chang-Min Choi
Jeong-Eun Yoo
author_sort Su-Ji Choi
collection DOAJ
description Background: Hominis placenta pharmacopuncture is widely used for climacteric symptoms. This study examined the efficacy and safety of pharmacopuncture with PLC (the extract of Hominis placenta) on hot flashes for perimenopausal and postmenopausal women. Methods: This study was a randomized placebo-controlled single-blind trial, which recruited 128 perimenopausal and postmenopausal women, randomly assigned to receive pharmacopuncture with PLC or normal saline (NS) for eight weeks. The primary outcome was the mean changes in the hot flash score (HFS) and the secondary outcomes were the mean changes in the Menopause Rating Scale (MRS), follicle-stimulating hormone (FSH) levels, and estradiol (E2) levels from baseline to eight weeks. Missing values were imputed using the last-observation-carried-forward method. Results: After treatment (week 9), the HFS decreased significantly in both groups (p = 0.000). The residual HFS was 47.09 ± 41.39% and 56.45 ± 44.92 % in the PLC and control groups, respectively (p = 0.262). One month after the treatment (week 13), the score of the PLC group was reduced, but the score increased in the control group (p = 0.077). There were no statistically significant differences in the mean changes in MRS, FSH, and E2 between the two groups. No serious adverse events related to this trial were noted. Conclusion: In this study, Hominis placenta extract pharmacopuncture did not differ significantly from NS in reducing the hot flash score. While this therapy appears safe, the potential for long-term effect of PLC extract needs to be examined in a large randomized controlled trial with appropriate controls. Trial registration: Clinical Research Information Service, Republic of Korea, KCT0 0 03533.
format Article
id doaj-art-950f8c26b4e8412c8611718d5fb5ea3c
institution OA Journals
issn 2213-4220
language English
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Integrative Medicine Research
spelling doaj-art-950f8c26b4e8412c8611718d5fb5ea3c2025-08-20T01:58:23ZengElsevierIntegrative Medicine Research2213-42202022-12-0111410089110.1016/j.imr.2022.100891Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal womenSu-Ji Choi0Dong-Il Kim1Sang Ho Yoon2Chang-Min Choi3Jeong-Eun Yoo4Department of Korean Obstetrics & Gynecology, College of Korean Medicine, Dong-Guk University, Korean Medicine Hospital, Goyang, Republic of KoreaDepartment of Korean Obstetrics & Gynecology, College of Korean Medicine, Dong-Guk University, Korean Medicine Hospital, Goyang, Republic of Korea; Corresponding author at: Department of Korean Obstetrics & Gynecology, College of Korean Medicine, Dong-Guk University, Korean Medicine Hospital, 27 Dongguk-ro, Ilsandong-gu, Goyang, Gyeonggi-do 10326, Republic of Korea.Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, Republic of KoreaDepartment of Korean Gynecology, College of Korean Medicine, Wonkwang University, Iksan, Republic of KoreaLaon Korean Medicine Clinic, Daejeon, Republic of KoreaBackground: Hominis placenta pharmacopuncture is widely used for climacteric symptoms. This study examined the efficacy and safety of pharmacopuncture with PLC (the extract of Hominis placenta) on hot flashes for perimenopausal and postmenopausal women. Methods: This study was a randomized placebo-controlled single-blind trial, which recruited 128 perimenopausal and postmenopausal women, randomly assigned to receive pharmacopuncture with PLC or normal saline (NS) for eight weeks. The primary outcome was the mean changes in the hot flash score (HFS) and the secondary outcomes were the mean changes in the Menopause Rating Scale (MRS), follicle-stimulating hormone (FSH) levels, and estradiol (E2) levels from baseline to eight weeks. Missing values were imputed using the last-observation-carried-forward method. Results: After treatment (week 9), the HFS decreased significantly in both groups (p = 0.000). The residual HFS was 47.09 ± 41.39% and 56.45 ± 44.92 % in the PLC and control groups, respectively (p = 0.262). One month after the treatment (week 13), the score of the PLC group was reduced, but the score increased in the control group (p = 0.077). There were no statistically significant differences in the mean changes in MRS, FSH, and E2 between the two groups. No serious adverse events related to this trial were noted. Conclusion: In this study, Hominis placenta extract pharmacopuncture did not differ significantly from NS in reducing the hot flash score. While this therapy appears safe, the potential for long-term effect of PLC extract needs to be examined in a large randomized controlled trial with appropriate controls. Trial registration: Clinical Research Information Service, Republic of Korea, KCT0 0 03533.http://www.sciencedirect.com/science/article/pii/S2213422022000580Hot flashesHominis PlacentaPharmacopunctureMenopauseClimacteric
spellingShingle Su-Ji Choi
Dong-Il Kim
Sang Ho Yoon
Chang-Min Choi
Jeong-Eun Yoo
Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal women
Integrative Medicine Research
Hot flashes
Hominis Placenta
Pharmacopuncture
Menopause
Climacteric
title Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal women
title_full Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal women
title_fullStr Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal women
title_full_unstemmed Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal women
title_short Randomized, single-blind, placebo-controlled trial on Hominis placenta extract pharmacopuncture for hot flashes in peri- and post-menopausal women
title_sort randomized single blind placebo controlled trial on hominis placenta extract pharmacopuncture for hot flashes in peri and post menopausal women
topic Hot flashes
Hominis Placenta
Pharmacopuncture
Menopause
Climacteric
url http://www.sciencedirect.com/science/article/pii/S2213422022000580
work_keys_str_mv AT sujichoi randomizedsingleblindplacebocontrolledtrialonhominisplacentaextractpharmacopunctureforhotflashesinperiandpostmenopausalwomen
AT dongilkim randomizedsingleblindplacebocontrolledtrialonhominisplacentaextractpharmacopunctureforhotflashesinperiandpostmenopausalwomen
AT sanghoyoon randomizedsingleblindplacebocontrolledtrialonhominisplacentaextractpharmacopunctureforhotflashesinperiandpostmenopausalwomen
AT changminchoi randomizedsingleblindplacebocontrolledtrialonhominisplacentaextractpharmacopunctureforhotflashesinperiandpostmenopausalwomen
AT jeongeunyoo randomizedsingleblindplacebocontrolledtrialonhominisplacentaextractpharmacopunctureforhotflashesinperiandpostmenopausalwomen